Zanotti, I.
465  results:
Search for persons X
?
 
?
5

Role of Sphingosine 1-phosphate (S1P) and its receptor S1P3..:

Zanotti, I. ; Greco, D. ; Battista, S....
Nutrition, Metabolism and Cardiovascular Diseases.  27 (2017)  1 - p. e43 , 2017
 
?
6

Modulazione dell'omeostasi del colesterolo da parte di Prop..:

Adorni, M.P. ; Zanotti, I. ; Cipollari, E....
Nutrition, Metabolism and Cardiovascular Diseases.  27 (2017)  1 - p. e4 , 2017
 
?
7

Cholesterol efflux capacity modulation by the nutraceutical..:

Piemontese, A. ; Battista, S. ; Romain, C....
Nutrition, Metabolism and Cardiovascular Diseases.  27 (2017)  1 - p. e31-e32 , 2017
 
?
10

UniPR129 is a competitive small molecule Eph-ephrin antagon..:

Hassan-Mohamed, I ; Giorgio, C ; Incerti, M...
British Journal of Pharmacology.  171 (2014)  23 - p. 5195-5208 , 2014
 
?
11

The thienotriazolodiazepine Ro 11‐1464 increases plasma apo..:

Zanotti, I ; Maugeais, C ; Pedrelli, M...
British Journal of Pharmacology.  164 (2011)  6 - p. 1642-1651 , 2011
 
?
12

Abstract: P446 ROLE OF APOLIPOPROTEIN E IN THE REVERSE CHOL..:

Zanotti, I ; Potì, F ; Pedrelli, M..
Atherosclerosis Supplements.  10 (2009)  2 - p. e756 , 2009
 
?
13

Severe HDL deficiency due to novel defects in the ABCA1 tra..:

Pisciotta, L. ; Bocchi, L. ; Candini, C....
Journal of Internal Medicine.  265 (2009)  3 - p. 359-372 , 2009
 
?
14

[127] CYCLOSPORINE A MODULATES THE MACROPHAGE REVERSE CHOLE..:

Zanotti, I. ; Stomeo, G. ; Zimetti, F...
Nutrition, Metabolism and Cardiovascular Diseases.  19 (2009)  - p. S31 , 2009
 
?
15

Abstract: 1456 DYB186LC INCREASES PLASMA APOA-I AND PROMOTE..:

Zanotti, I ; Pedrelli, M ; Kempen, H..
Atherosclerosis Supplements.  10 (2009)  2 - p. e96 , 2009
 
1-15